ResMed Financial Diagnostics

ResMed Inc -- USA Stock  

USD 100.35  12.84  14.67%

ResMed Inc diagnostics interface makes it easy to digest most current publicly released information about ResMed as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis ResMed price relationship with some important fundamental indicators such as market cap and management efficiency.
About 66.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.88. ResMed Inc last dividend was issued on 2017-11-08. This company had 2:1 split on 2010-08-31. ResMed Inc. designs, develops, manufactures, and markets medical devices and cloudbased software applications that diagnose, treat, and manage respiratory disorders. To find out more about RESMED INC contact Michael Farrell at 858 836-5000 or learn more at www.resmed.com.

ResMed Inc Alerts

ResMed Inc appears to be very risky and stock price may revert if volatility continues
ResMed Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
About 66.0% of the company shares are owned by institutional investors
Latest headline from www.fool.com: Here Why ResMed Inc. Is Soaring Today

ResMed Inc Upcoming Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017

ResMed Inc EPS Estimate

EPSEstimate Date
Quarterly Estimate0.7April 25, 2017

ResMed SEC Filings

Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
Financial Statements and Exhibits. Other Events
Unclassified Corporate Event

Institutional Investors

Security TypeSharesValue
Schwab Charles Investment Management IncCommon Shares689.7 K58.4 M
Crestwood Advisors Group LlcCommon Shares211.5 K17.9 M
Capital Investment Services Of America IncCommon Shares183.2 K15.5 M
National Pension ServiceCommon Shares167.6 K14.2 M
Professional Advisory Services IncCommon Shares138.4 K11.7 M
Bank Of MontrealCommon Shares136.6 K11.6 M
Gateway Investment Advisers LlcCommon Shares118.7 K10.1 M

Market Capitalization

The company currently falls under 'Large-Cap' category with total capitalization of 12.6 B.

Profitablity

The company has Net Profit Margin of 16.58 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 22.36 % which entails that for every 100 dollars of revenue it generated 0.22 of operating income.

Management Efficiency

ResMed Inc has Return on Asset of 8.72 % which means that on every $100 spent on asset it made $8.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.43 % implying that it generated $18.43 on every 100 dollars invested.

Stock Holders for ResMed

Information
Ratio
Value
At Risk
NASDAQ NNASDAQ N America Large Mid Cap(0.4) (0.77) 
VanguardVanguard SP Mid Cap 400 Index I(0.076) (0.55) 
VPMSXVantagepoint MidSmall Company Index II 0.00  0.00 
VALICVALIC Company I Mid Cap Index(0.0787) (0.54) 
UMPSXProFunds UltraMid Cap Svc(0.23) (7.47) 
UMPIXProFunds UltraMid Cap Inv(0.22) (6.26) 
MotleyMotley Fool Great America Investor(0.14) (0.86) 
SSgA SPDRSSgA SPDR ETFs Europe I Public Limited Company SPDR SP 400 US Mid Cap UCITS ETF(0.37) (0.6) 
SSgA SPDRSSgA SPDR ETFs Europe I Public Limited Company SPDR SP 400 US Mid Cap UCITS ETF(0.12) (0.59) 
SPDR SPSPDR SP 400 US Mid Cap ETF(0.32) (1.11) 
SheltonShelton SP Midcap Index Direct(0.1) (0.72) 
IsharesIshares Trust(0.1) (1.89) 
Schwab USSchwab US Mid Cap ETF(0.0502) (0.5) 
Rydex MidRydex Mid Cap 1 5x Strategy H 0.0046 (0.79) 
GuggenheimGuggenheim SP 500 Eq Weight HC ETF 0.11 (0.38) 
Rydex MidRydex Mid Cap 1 5x Strategy C 0.0798 (0.79) 
Rydex MidRydex Mid Cap 1 5x Strategy A 0.0841 (0.78) 
PrincipalPrincipal MidCap SP 400 Index R1(0.24) (0.73) 
NusharesNushares ESG Midcap Growth ETF(0.0223) (0.7) 
NorthernNorthern Mid Cap Index(0.23) (0.7) 

Technical Drivers

ResMed Inc holds Standard Deviation of 3.2, Downside Deviation of 1.05 and Risk Adjusted Performance of 0.1143. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of ResMed as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found eighteen technical drivers for ResMed Inc which can be compared to its competitors. Please check ResMed Inc Jensen Alpha, Potential Upside as well as the relationship between Potential Upside and Skewness to decide if ResMed Inc is priced some-what accurately providing market reflects its current price of 100.35 per share. Given that ResMed has Treynor Ratio of 0.6457, we recommend you check out ResMed Inc recent market performance to make sure the company can sustain itself at future point.

ResMed Inc Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ResMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ResMed Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Stakeholder Activities

ResMed Inc Insider Trading

Corporate Filings

ResMed Corporate Reports
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations